The use of erythropoietin in neonates (Q34032616)

30 July 2017

1 reference

title

The use of erythropoietin in neonates (English)

1 reference

30 July 2017

1 reference

Ohls RK

1 reference

30 July 2017

publication date

1 September 2000

1 reference

30 July 2017

published in

Clinics in Perinatology

1 reference

30 July 2017

1 reference

30 July 2017

1 reference

30 July 2017

page(s)

681-696

1 reference

Erythropoietin therapy in neonates at risk of having bronchopulmonary dysplasia and requiring multiple transfusions

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Effect of booster blood transfusions on oxygen utilization in infants with bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Effects of theophylline on erythropoietin production in normal subjects and in patients with erythrocytosis after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Myocardial, erythropoietic, and metabolic adaptations to anemia of prematurity in infants with bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Effect of low and moderate doses of recombinant human erythropoietin on the haematological response in premature infants on a high protein and iron intake

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Weekly intravenous administration of recombinant human erythropoietin in infants with the anaemia of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Expression of the erythropoietin gene

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Minimizing donor blood exposure in the neonatal intensive care unit. Current trends and future prospects.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Relationship between determinants of oxygen delivery and respiratory abnormalities in preterm infants with anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Decreased response of plasma immunoreactive erythropoietin to "available oxygen" in anemia of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Single-dose pharmacokinetics of recombinant human erythropoietin in preterm infants after intravenous and subcutaneous administration

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Comparison between two and five doses a week of recombinant human erythropoietin for anemia of prematurity: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Oxygen sensing and molecular adaptation to hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Evaluation of the mechanism causing anemia in infants with bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Endothelin concentrations in preterm infants treated with human recombinant erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Renal and extrarenal erythropoietin production in anaemic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Effects of recombinant human erythropoietin in infants with the anemia of prematurity: A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Increased hematocrit and decreased transfusion requirements in children given erythropoietin before undergoing craniofacial surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Sustained receptor activation and hyperproliferation in response to granulocyte colony-stimulating factor (G-CSF) in mice with a severe congenital neutropenia/acute myeloid leukemia-derived mutation in the G-CSF receptor gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Lactic acid as a predictor for erythrocyte transfusion in healthy preterm infants with anemia of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

The effect of blood transfusion on oxygenation in premature ventilated neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Serum erythropoietin levels during infancy: Associations with erythropoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Score for neonatal acute physiology and phlebotomy blood loss predict erythrocyte transfusions in premature infants

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Pharmacokinetics and pharmacodynamics of erythropoietin during therapy in an infant with renal failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Late hyporegenerative anemia in Rh hemolytic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Investigating erythropoietin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Myocardial, erythropoitic, and metabolic adaptations to anemia of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

High-versus low-dose erythropoietin in extremely low birth weight infants. The European Multicenter rhEPO Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Lack of transport of erythropoietin across the human placenta as studied by an in vitro perfusion system

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

The Effect of Recombinant Human Erythropoietin on Circulating Hematopoietic Progenitor Cells in Anemic Premature Infants

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Anaemia of prematurity. Epidemiology, management and costs

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Effects of intravascular, intrauterine transfusion on prenatal and postnatal hemolysis and erythropoiesis in severe fetal isoimmunization

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: A randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

A randomized, double-blind, placebo-controlled trial of recombinant erythropoietin in treatment of the anemia of bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Erythroid "burst promoting" activity in serum of patients with the anemia of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Pharmacokinetics and effectiveness of recombinant erythropoietin administered to preterm infants by continuous infusion in total parenteral nutrition solution

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Responsiveness to recombinant human erythropoietin of marrow erythroid progenitors from infants with the "anemia of prematurity"

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Effects of dexamethasone on erythroid colony and burst formation from human fetal liver and adult marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Suppression of erythropoiesis by intrauterine transfusions in hemolytic disease of the newborn: Use of erythropoietein to treat the late anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Epoetin alfa therapy in infants awaiting heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Circulating erythroid progenitors in the anemia of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Erythropoietin in pediatric cardiac surgery: clinical efficacy and effective dose.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Recombinant human erythropoietin vs transfusions in the treatment of anemia of prematurity. A cost-benefit analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

The anemia of prematurity. Factors governing the erythropoietin response

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Anemia of prematurity: determinants of the erythropoietin response

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Erythropoietin levels and erythropoiesis at birth in infants with Potter syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Changing patterns of red blood cell transfusion in very low birth weight infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

Erythropoietin does not cross the placenta into the fetus

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2805%2970045-2

7 January 2021

10.1016/S0095-5108(05)70045-2

Identifiers

DOI

1 reference

30 July 2017

1 reference